Cargando…
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Thoracic Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605181/ https://www.ncbi.nlm.nih.gov/pubmed/32897730 http://dx.doi.org/10.1164/rccm.202007-2778LE |
| _version_ | 1783604261934858240 |
|---|---|
| author | Zelek, Wioleta M. Cole, Jade Ponsford, Mark J. Harrison, Richard A. Schroeder, Ben E. Webb, Nicholas Jolles, Stephen Fegan, Christopher Morgan, Matt Wise, Matt P. Morgan, B. Paul |
| author_facet | Zelek, Wioleta M. Cole, Jade Ponsford, Mark J. Harrison, Richard A. Schroeder, Ben E. Webb, Nicholas Jolles, Stephen Fegan, Christopher Morgan, Matt Wise, Matt P. Morgan, B. Paul |
| author_sort | Zelek, Wioleta M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7605181 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Thoracic Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76051812020-11-02 Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19 Zelek, Wioleta M. Cole, Jade Ponsford, Mark J. Harrison, Richard A. Schroeder, Ben E. Webb, Nicholas Jolles, Stephen Fegan, Christopher Morgan, Matt Wise, Matt P. Morgan, B. Paul Am J Respir Crit Care Med Correspondence American Thoracic Society 2020-11-01 2020-11-01 /pmc/articles/PMC7605181/ /pubmed/32897730 http://dx.doi.org/10.1164/rccm.202007-2778LE Text en Copyright © 2020 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org). |
| spellingShingle | Correspondence Zelek, Wioleta M. Cole, Jade Ponsford, Mark J. Harrison, Richard A. Schroeder, Ben E. Webb, Nicholas Jolles, Stephen Fegan, Christopher Morgan, Matt Wise, Matt P. Morgan, B. Paul Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19 |
| title | Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19 |
| title_full | Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19 |
| title_fullStr | Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19 |
| title_full_unstemmed | Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19 |
| title_short | Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19 |
| title_sort | complement inhibition with the c5 blocker lfg316 in severe covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605181/ https://www.ncbi.nlm.nih.gov/pubmed/32897730 http://dx.doi.org/10.1164/rccm.202007-2778LE |
| work_keys_str_mv | AT zelekwioletam complementinhibitionwiththec5blockerlfg316inseverecovid19 AT colejade complementinhibitionwiththec5blockerlfg316inseverecovid19 AT ponsfordmarkj complementinhibitionwiththec5blockerlfg316inseverecovid19 AT harrisonricharda complementinhibitionwiththec5blockerlfg316inseverecovid19 AT schroederbene complementinhibitionwiththec5blockerlfg316inseverecovid19 AT webbnicholas complementinhibitionwiththec5blockerlfg316inseverecovid19 AT jollesstephen complementinhibitionwiththec5blockerlfg316inseverecovid19 AT feganchristopher complementinhibitionwiththec5blockerlfg316inseverecovid19 AT morganmatt complementinhibitionwiththec5blockerlfg316inseverecovid19 AT wisemattp complementinhibitionwiththec5blockerlfg316inseverecovid19 AT morganbpaul complementinhibitionwiththec5blockerlfg316inseverecovid19 |